North American Report

NHU Provides Key Raw Materials for COVID-19 Medical Treatments

 Breaking News
  • No posts were found

NHU Provides Key Raw Materials for COVID-19 Medical Treatments

June 20
14:24 2022

NHU held a Kick Off Meeting for the commissioning of the CLA project at its Shangyu production base. CLA project is an important milestone for NHU to dive deep into the API business, marking a solid step on the way towards becoming a “chemical expert in the pharmaceutical sector”. The successful implementation of the project will help NHU to contribute to the easing of the harsh condition caused by the epidemic, and to the better health and life of mankind.

Mr. Hu Baishan, Vice Chairman and President of NHU called for all managers and employees to devote themselves in the commissioning of the CLA project with higher sense of mission and responsibility at the KO meeting. He stressed our corporate purpose of Elevating Employees and Benefiting the Society and advocated NHUers to contribute to improving health and life of people and securing the stable development of the society.

To ramp up the prevention and control of the epidemic, the National Health Commission recently released the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial 7th Edition), and nirmatrelvir/ritonavir (sold under the name Paxlovid), which was approved for emergency use by NMPA, was included in the therapy as a new specific anti-coronavirus drug.

Paxlovid is an antiviral compound that co packs nirmatrelvir (150mg) and ritonavir (100mg). The caronic anhydride and azabicyclo produced by NHU in its prenol industrial chain can be used for the production of nirmatrelvir.

As an innovative company specialized in nutrition, health, and new polymer materials, 

NHU has been upholding the mission of Exploring Chemistry, Improving Life, and creating better lives for all with the power of chemical technology. 

In the case of the CLA project, NHU has leveraged its advantages in raw materials, technologies, marketplace, and industrialization processes to finish the bench-scale and pilot-scale test in merely 1 week and 40 days respectively, and successfully launched commissioning in just 4 months.

Going forward, NHU will continue to pursue its corporate purpose, promote R&D and technology transfer to deliver benefit to the society, help address various challenges including global resources, energy, and health, and make greater contributions to improve life of mankind. 

Media Contact
Company Name: Lingrong Culture
Contact Person: Wang Yurong
Email: Send Email
Phone: 2134007851
Address:3185 Wilshire blvd
City: Los Angeles
State: CA
Country: United States